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Summary
 
Here, we report data concerning the discovery in adult human peripheral blood of a precursor
cell population able to differentiate into CD4
 
1
 
CD3
 
1
 
ab
 
1
 
 mature T cells. These cells, which
represent 0.1–0.5% of total peripheral blood mononuclear cells (PBMC), express substantial
levels of CD4, but lack CD3 surface expression. At a molecular level, they express the pre-T
cell receptor 
 
a
 
 (pT
 
a
 
) gene, CD3-
 
g
 
, CD-
 
d
 
 and CD-
 
e
 
, and 
 
RAG-1
 
 recombination enzyme and
have initiated rearrangements in the T cell receptor (TCR)-
 
b
 
 locus (D–J). Moreover, low lev-
els of CD3
 
e
 
 protein, but not of TCR-
 
b
 
 chain, can be detected in their cytoplasm. Our results
suggest that CD4
 
1
 
CD3
 
2
 
 cells identified in peripheral blood are different from CD3
 
2
 
CD4
 
1
 
CD8
 
2
 
thymocytes and may contain precursors of an extrathymic T cell differentiation pathway.
 
I
 
n murine T cell development, early thymocytes that pro-
ductively rearrange the TCR-
 
b
 
 locus are selected to
continue maturation. This happens because of the coupling
of the rearranged 
 
b
 
 chain with the invariant pre–TCR-
 
a
 
(pT
 
a
 
)
 
1
 
 protein (1, 2). This pre-TCR regulates early T cell
development; later stages are under the control of the
mature TCR, composed of the 
 
a
 
 and 
 
b
 
 chains (3). The
TCR-
 
b
 
–pT
 
a
 
 heterodimer is associated with CD3 mole-
cules (4), and signals triggered by the pre-TCR induce ex-
pansion and differentiation of immature precursor cells (5).
Analysis of pT
 
a
 
 gene-deficient mice provided formal proof
that expression of the pre-TCR is required in the transition
of CD25
 
1
 
 double-negative (DN) T cell precursors into
small CD4
 
1
 
CD8
 
1
 
 thymocytes (5). This transition normally
occurs through a stage in which maturing thymocytes pro-
liferate vigorously and lose the expression of CD25. Nev-
ertheless, low levels of mature 
 
ab
 
 T cells can be detected in
the periphery of pT
 
a
 
 knockout mice, suggesting that the
expression of pT
 
a
 
 is necessary for quantitative expansion of
maturing thymocytes, but not crucial for differentiation.
Using murine pT
 
a
 
 cDNA as a probe, we were able to
show that a comparable gene was expressed in human thy-
mocytes (6). Amino acid sequence comparison between
human and mouse pT
 
a
 
 cDNAs revealed high sequence
homology in the extracellular as well as the transmembrane
region, but complete divergence in the cytoplasmic region.
Recently, another group cloned human pT
 
a
 
 cDNA and
performed a comparison of the developmental regulation of
pT
 
a
 
, TCR-
 
b
 
, TCR-
 
a
 
, and 
 
RAG-1
 
 gene expression, pro-
viding a picture of the maturational progression of early
human intrathymic stages (7).
We have previously shown that murine pT
 
a
 
 expression
is exquisitely T lineage specific and occurs in pro-T cells
outside the thymus, in the earliest T cell precursors identi-
fied in the thymus, and in sites that support extrathymic T cell
development (gut and liver), (8). Consistent with these ob-
servations, pT
 
a
 
 RNA could not be detected in human
non–T cells including B, NK, myeloid, and dendritic cells
(7). Here, we have used the expression of the pT
 
a
 
 gene as
a tool to identify a human T cell precursor in the peripheral
blood of adult donors.
 
Material and Methods
 
Antibodies.
 
Cell staining was performed using the following
mouse anti–human mAbs: phycoerythrin-conjugated (R-PE)–CD4,
fluorescein-conjugated FITC–CD3, FITC–CD14, R-PE–CD5,
biotin–CD10, R-PE–CD33, biotinylated HLA-DR, and RPE–
CD34 (Becton Dickinson, San Jose, CA); tricolor CD4, biotiny-
lated CD2 and RPE–CD7 (Caltag Laboratories, San Francisco, CA),
CD45RA (IgG2b) and B7-2 (IgG2b) (PharMingen, San Diego,
CA), FITC–pan-TCR-
 
ab
 
 (T Cell Diagnostic, Inc., Boston, MA).
To deplete samples from CD3
 
1
 
 cells, we used TR66 mAb (9)
that was FITC conjugated according to standard procedures. For
TCR-
 
b
 
 cytoplasmic staining we used HB-9283 supernatant (Amer-
 
1
 
Abbreviations used in this paper:
 
 ACDU, automatic cell deposit unit tech-
nique; CB, cord blood; DN, double negative; DP, double positive;
FTOC, fetal thymic organ culture; GL, germline; HS, human serum; ISP,
immature single positive; MMLV, murine maloney leukemia virus; pT
 
a
 
,
pre-T cell receptor 
 
a
 
 gene; SP, single positive.
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ican Type Culture Collection). Second-step antibodies used were
goat anti–mouse IgG1 R-PE or FITC conjugated (Southern Bio-
technology Associates, Inc.)
 
Surface Staining and Sorting of Lymphocytes.
 
PBMC were sepa-
rated from 50–60 ml blood from 25–33-yr-old male volunteers
by standard Ficoll gradient centrifugation, resuspended in PBS
containing 2% FCS at 10
 
7
 
 cells per ml, and stained following stan-
dard procedures. Stained samples were analyzed and sorted on ei-
ther FACScan
 
Ò
 
, FACStar Plus
 
Ò
 
, or FACS Vantage
 
Ò
 
. Sorted pop-
ulations were reanalyzed by the same machines to test purity.
 
Cell Depletion.
 
A single-cell suspension was first stained, as
described previously, with FITC-conjugated TR66 mAb and, sub-
sequently, PBMC were depleted of CD3
 
1
 
 cells using Dynabeads
(Milan, Switzerland).
 
Cytoplasmic Staining.
 
Sorted cells (0.5–1 
 
3
 
 10
 
5
 
) were washed
twice in PBS and fixed in 500 
 
m
 
l of 2% paraformaldehyde for 20
min at room temperature. Samples were washed again twice with
PBS and, subsequently, lysed in 1 ml Saponin buffer (0.5% Sapo-
nin, 10 mM Hepes, 5% FCS) for 10 min at room temperature.
Samples were then stained for 30 min at room temperature with
HB-9283 supernatant specific for TCR-
 
b
 
 cytoplasmic chain or
CD3–FITC. After washing twice with Saponin buffer, goat anti–
mouse IgG1 R-PE antibody was added in the case of TCR-
 
b
 
 cy-
toplasmic staining. As background controls, for the TCR-
 
b
 
 cyto-
plasmic staining we used the second-step antibody alone (goat
anti–mouse IgG1 R-PE) and for CD3 cytoplasmic staining an ir-
relevant FITC-conjugated antibody (CD20; Becton Dickinson).
 
Cell Cycle Analysis.
 
Sorted cells (0.5–1 
 
3
 
 10
 
5
 
) were fixed in 2
ml 70% ethanol at 4
 
8
 
C overnight. Samples were than centrifuged
at 2,000 rpm for 5 min and resuspended in 250 
 
m
 
l RNAse A
(Sigma, Buchs, Switzerland) (0.5 mg/ml in 0.1 M Tris, pH 7.5,
0.1 M NaCl) and incubated for 30 min at 37
 
8
 
C. Without centri-
fuging, 250 
 
m
 
l pepsin (Sigma, Buchs, Switzerland) (1 mg/ml in
0.4% HCl) were added and samples were incubated for 15 min at
37
 
8
 
C. Without centrifuging, 500 
 
m
 
l ethidium bromide (0.02 mg/ml,
0.2 M Tris, pH 8–8.5, 0.5% BSA) were added and samples were
incubated for another 15 min at room temperature protected
from light with aluminum foil. At the end of incubation, samples
were kept on ice until analysis. Analysis was performed on a
FACScan
 
Ò
 
, equipped with the doublets discriminating module
(DDM).
 
Reverse Transcription–PCR.
 
In the analysis of pT
 
a
 
 and CD3
expression in the total population, cells (0.5 
 
3
 
 10
 
5
 
) were directly
sorted into 500 
 
m
 
l of RNAzol (Cinna Scientific, Houston, TX)
in Eppendorf tubes. Total RNA was extracted according to the
protocol of the manufacturer. cDNA was prepared with random
hexamer primers and reverse transcribed with a Superscript kit
(GIBCO BRL, Gaithersburg, MD). In the analysis of pT
 
a
 
 ex-
pression in a limited amount of cells, we used the automatic cell
deposit unit technique (ACDU): cells (50, 20, 10, 5, and 1) were
directly sorted in 5 
 
m
 
l PBS in 96-well PC plates type H (Costar,
Cambridge, MA). After sorting, plates were immediately put on
dry ice and left for 30 min. cDNA was made directly in the plates
after heating for 2 min at 95
 
8
 
C using MMLV reverse transcriptase
and random hexamer primers at 37
 
8
 
C. Primers used were oligo-
nucleotides specific for pT
 
a
 
 (5
 
9
 
-GGCACACCCTTTCCTTCT-
CTG-3
 
9
 
 and 5
 
9
 
-GCAGGTCCTGGCTGTAGAAGC-3
 
9
 
), for CD3
 
e
 
(5
 
9
 
-GTCTCCATCTCTGGAACCACAG-3
 
9
 
 and 5
 
9
 
-GGCCT-
TTCTATTCTTGCTCCAG-3
 
9
 
), for CD3
 
g
 
 (5
 
9
 
-GGAGGA-
ATTCACTGACATGGAACAGGGGAAGG-3
 
9
 
 and 5
 
9
 
-ACT-
CGAATTCCTGAGTTCAATTCCTCCTCAAC-3
 
9
 
), for CD3
 
d
 
(5
 
9
 
-GTGAATTGCAATACCAGCATC-3
 
9
 
 and 5
 
9
 
-GCTGTA-
CTGAGCATCATCTC-3
 
9
 
) and for 
 
RAG-1
 
 (5
 
9-CCAAATTG-
CAGACATCTCAAC-39 and 59-CAACATCTGCCTTCACAT-
CGATCC-39) gene transcripts. PCRs were done in a 30 ml
reaction mixture containing 50 mM KCl, 10 mM Tris–HCl (pH
8.3), 1.5 mM MgCl2, 10 mM mixed dNTP, 10 pM of each oli-
gonucleotide primer, and 1 U AmpliTaq DNA polymerase
(Roche Diagnostic System). DNA was amplified for 35 cycles at
an annealing temperature of 558C for pTa and RAG-1 and 638C
for CD3 with a thermal cycling machine (Perkin-Elmer Cetus).
A 9-ml portion of each amplified product was examined by 1.3%
agarose gel electrophoresis and stained with ethidium bromide. In
the case of ACDU procedure, a first PCR was done directly in
the plates on total cDNA samples in 85 ml reaction at 558C an-
nealing temperature for 30 cycles using an Hybaid Omnigen
PCR machine. Subsequently, 2 ml of each sample was used for a
second PCR following the procedure described above. Primers
used were the same for both PCRs. Primers to detect DJb rear-
rangements at a transcriptional level were the following: 59-
TGGGAGGGGCTGTTTTTGT-39 and 59-GATCTCATAGA-
GGATGGTGGC-39.
DNA Extraction and PCR. DNA was prepared from cells by
directly sorting them in PBS. Subsequently, 5 ml of proteinase K
(20 mg/ml; Merck, Darmstadt, Germany) was added and sample
were left at 558C for 2 h. Phenol/chloroform extraction and
DNA precipitation followed, according to standard procedures.
PCR conditions were as described elsewhere (10) using TBF1
(upstream, the Db1 segment) and TBR1 (downstream, the Jb1–6
element) primers (10) for genomic DJb amplification.
Southern Blot Analysis. Some of the gels containing PCR
products were blotted for 2 h with 0.4N NaOH and subsequently
hybridized, according to standard procedures, with the following
different oligonucleotides: for RAG-1 gene product with 59-ACC-
ATCCACAGGACCATGGACTGG-39, for DJb rearrangements
of the TCR-b locus with TBR3 (10), for immature D–J–C tran-
scripts from the b locus with a Cb-specific oligo 59-GAGCCAT-
CAGAAGCAGAGATC-39.
Hybrid Human/Mouse Fetal Thymic Organ Cultures. The in vitro
development of human T cells was studied using the hybrid hu-
man/mouse fetal thymic organ culture (FTOC) (11). Fetal thymi
from embryos of RAG-1–deficient mice were dissected on day
15–16 of gestation and precultured for 5 d in the presence of 1.35
mM 2-deoxyguanosine (Sigma, St. Louis, MO) to remove en-
dogenous thymocytes. Next, the thymic lobes were cocultured
for 2 d in hanging drops in wells of a Terasaki plate with human
progenitor cells and transferred to nucleopore filters, which were
layered over gelfoam rafts in 6-well plates (Costar). The lobes
populated with human cells were cultured for the indicated num-
ber of days in Yssel’s medium (12) supplemented with 2% normal
human serum and 5% FCS. To analyze differentiation of human
cells, the mouse thymi were dispersed into single cell suspensions
and stained with mAbs specific for human cell surface antigens.
Liquid Cultures in the Presence of Cytokines. To test T cell dif-
ferentiation potential, 1 3 104 sorted cells were cocultured with
irradiated (3,000 rads) allogeneic PBMC as feeder cells in U-bot-
tomed 96-well plates in complete RPMI medium with 5% human
serum (HS), 0.1 mg/ml PHA, 1,000 U/ml IL-2, and 500 U/ml IL-7.
After 10 d, growing cells were stained and analyzed by FACSÒ.
Limiting Dilution Analysis. Flow cytometry–sorted progeni-
tor cells were carefully spun down and diluted in the same me-
dium described above for T cell differentiation, containing 1 3
106/ml irradiated allogeneic PBMC as feeder cells. 1 cell/well
was distributed in Terasaki plates. After 10–15 d, growing wells
were transferred in U-bottomed 96-well plates and cells stained
and analyzed by FACSÒ.877 Bruno et al.
Results
Identification of a pTa1 Population in Peripheral Blood. By
PCR analysis of retrotranscribed mRNA of PBMC of adult
donors we were able to detect low levels of pTa message
in all of the samples tested (data not shown; Fig. 1 B, lane 1).
Depletion of CD31 T cells from PBMC did not abrogate
the detection of pTa expression by PCR. This result was
expected, because mature T cells have completely lost ex-
pression of pTa (6–8). In view of our previously demon-
stration (6) that the thymic subset expressing the highest
levels of pTa is CD32CD41CD82 (immature single posi-
tive, ISP), we investigated whether expression of CD4 was
shared by pTa1 cells in PBMC. Fig. 1 demonstrates that
this is indeed the case, because sorted CD41, CD32 cells
(Fig. 1 A, shown in the box, R2) expressed pTa (Fig. 1 B,
lane 2). No pTa message could be detected in total PBMC
depleted of CD41CD32CD142 cells (Fig. 1 B, lane 3). Mon-
ocytes, which also express low levels of CD4 but are
CD32, were excluded from the selection by staining with a
specific mAb (CD14) and on the basis of their size (Fig. 1 A).
Interestingly, the physical parameters (FSC versus SSC) of
the pTa1 subset differ substantially from those of mature
lymphocytes and monocytes, in that pTa1 cells have a size
and a cell complexity intermediate between lymphocytes and
monocytes (Fig. 1 A, bottom). This cell population repre-
sents, in different healthy adult individuals analyzed (25–35
yr old), 3–9% of gated cells (R1) and 0.1–0.5% of the total
PBMC, obtained by Ficoll preparation.
Partial DJb Rearrangement and b Gene Transcription in
pTa1 Cells in Peripheral Blood. Rearrangement of B cell
(13) and T cell (14) antigen receptor gene loci to form
functional VDJ gene segments is a key molecular event in
lymphocyte ontogeny. In the thymus, DJb rearrangements
precede V(D)Jb rearrangements (15). Therefore, the pat-
tern of TCR b gene rearrangements represents a helpful
marker to assess the maturational stage of a given popula-
tion and its possible commitment to the T cell lineage. To
analyze the rearrangement status of the TCR-b locus (DJb
versus germline configuration) in the pTa1 population ob-
served in human peripheral blood, genomic DNA was iso-
lated from CD41CD32CD142 pTa1 cells, and a recently
described (10) PCR-based method was used, to amplify the
DJb1 gene region specifically. Relevant controls in which
Figure 1. (A) FACScanÒ analysis of presorted and sorted cells from PBMC. Mononuclear cells were separated from total PB by standard Ficoll gradient
centrifugation, CD3 depleted using FITC–TR66 mAb and stained with CD4–PE- and CD14–FITC-specific mAbs. Top left, CD3/CD14 versus CD4
staining pattern of cells gated through R1 (FSC versus SSC, bottom left). R1 determined by backgating R2 into FSC versus SSC (see also size pattern, bot-
tom right). Top and bottom right, cells after sorting (purity close to 100%). (B) CD41CD32CD142 sorted cells express pTa. RT–PCR analysis for the ex-
pression of pTa (top) and b-actin (bottom) was performed on total PBMC, CD41CD32CD142 sorted cells according to gates shown in A and total sorted
PBMC gating out CD41 CD32CD142 (PBMC, CD41CD32CD142). To ascertain that PCR products shown were derived from pTa cDNA, gels were
blotted and probed with a pTa-specific oligonucleotide (data not shown).878 Immature T Cells in Human Peripheral Blood
DNA was obtained either from CD41CD31 mature T lym-
phocytes, CD141 monocytes (obtained from FACSÒ sort-
ing), or from unseparated PBMC were run in parallel. The
primer combination used in this method allows to amplify,
in a single PCR reaction, a germline-derived DNA frag-
ment of 3 kb and/or several shorter DNA products derived
from DJb rearranged loci. PCR products are then blotted
and hybridized with an internal oligonucleotide probe.
Several DJb rearrangements (DJb1.3, DJb1.5, and DJb1.6)
could be demonstrated in genomic DNA from CD41CD32
CD142 progenitors, in addition to a dominant germline
band (GL) (Fig. 2 A). As expected, monocytes (CD141) were
characterized by the presence of an amplification product
only in germline configuration, while in mature T cells
(CD41CD31) and total PBMC all the different DJb rear-
rangements were present. As expected, a band correspond-
ing to germline gene configuration also could be detected
in PBMC because of the presence of non-T populations.
This result suggests the presence of T cell lineage commit-
ted cells within the pTa1 CD41CD32 population.
To ascertain whether the presence of DJb rearrange-
ments was paralleled by transcription of the rearranged genes,
we tested for the presence of transcripts corresponding to
the partial DJb rearrangements by RT–PCR. Total RNA
was isolated from sorted peripheral populations (CD41CD32
CD142 and CD141) or total PBMC and reverse tran-
scribed into cDNA before amplification with a primer spe-
cific for the upstream Db1 sequence together with a Cb-
specific primer. PCR products were analyzed by Southern
blotting with an internal oligo specific for the Cb region.
All cDNA were controlled for integrity with b-actin prim-
ers before D–J–C amplification (data not shown). Results
are shown in Fig. 2 B, in which the presence of a transcript
of 600 bp, corresponding to partial DJb rearrangement, is
detected both in unfractionated PBMC and sorted CD41
CD32CD142 cells, but not in CD141 monocytes. Taken
together, these results show that both rearrangement of,
and transcription from TCR-b loci are present in a fraction
of the pTa1 cell population present in peripheral blood.
The CD41CD32CD142 Cell Population Expresses RAG-1
Gene and Is Not Cycling. Previous studies have shown that
analysis of the expression of RAG-1 and RAG-2 genes and
of TCR transcription are useful to trace early events during
T cell development both in murine and in human T cell
development (7, 16). As independent confirmation of DJb
rearrangement of the TCR-b locus of CD41CD32CD142
cells, we tested for RAG-1 gene expression in two different
preparations of CD41CD32CD142 cells from human pe-
ripheral blood. RAG-1 message could indeed be detected
in both preparations (Fig. 3 A, lanes 1 and 2), as well as in
DN cells from thymus, but not in mature CD41CD31 T
cells.
Because CD32CD41CD82 immature thymocytes are
actively cycling, we then asked whether peripheral pTa1,
CD41CD32CD142 cells were also characterized by active
proliferation. Analysis of DNA content in the potential T cell
precursor population revealed that all of the cells were in
G0–G1 phase of the cell cycle, while TCR-ab1 Jurkat T
cell line showed also G2–S phases (Fig. 3 B). Thus, CD41
CD32CD142 cells are in a resting state, express RAG-1
and pTa, and carry DJ rearrangements at the TCR-b locus.
Cell Surface Phenotype Analysis. CD41CD32CD142 cells
were isolated by flow cytometry as described above (see
Figure 2. Detection of partial (D–J) rearrangements of the TCR-b lo-
cus. (A) At DNA level. Genomic DNA was isolated from sorted
CD41CD32CD142, CD41CD31, CD141, and total PBMC and ampli-
fied by PCR using TBF1 and TBR1 primers to detect Db1–Jb1 rear-
rangements. Normal PBMC and monocytes (CD141) were used as posi-
tive and negative controls, respectively. PCR products were blotted and
hybridized with TBR3 probe. PCR products, ranging from 200 to 3,000
bp, and the Jb segment used are indicated. GL, germline. (B) At RNA
level. Total RNA was first isolated from sorted CD41CD32CD142,
CD141, and from total PBMC and, subsequently, RT–PCR using TBF1
and Cb primer set was performed. PCR products were blotted and
probed with a Cb-specific primer.
Figure 3. CD41CD32CD142 cell population expresses RAG-1 and is
not cycling. (A) RT–PCR analysis on two different samples of sorted
CD41CD32CD142 PBMC (1, 2), mature T cells (CD41CD31) and DN
thymocytes (DN Thymus). PCR products were blotted and probed with a
RAG-1-specific oligonucleotide. (B) Cell cycle analysis on sorted
CD41CD32CD142 (top) and on Jurkat T cell line (bottom).879 Bruno et al.
Fig. 1) and subsequently stained with a set of monoclonal
antibodies specific for cell surface markers. Fig. 4 shows
that sorted cells homogeneously expressed high levels of
CD45RA, intermediate levels of MHC class II HLA-DR,
low levels of the costimulatory molecule B7-2, but did not
express the hematopoietic progenitor cell surface antigen
CD34 or the neutral endopeptidase CD10, both present on
a T, B, NK, and DC cell precursor population recently de-
scribed in human bone marrow (17). Only a very small
fraction, around 2–5% of sorted cells, expressed CD5 and
CD7, found on mature and immature T cells. A higher
fraction, 15–40% depending on the different individuals
analyzed, expressed the T- and NK-specific molecule
CD2. CD33, expressed on myeloid progenitors and mono-
cytes, also presented a bimodal distribution with most of
the cells expressing low levels of the marker (CD33dim).
Both CD331 and CD332 cells expressed pTa (data not
shown). CD41CD32CD142 cells did not exhibit detect-
able levels of the lineage-specific cell markers CD1a, CD8,
CD16, and CD56, CD19 and CD20, gd TCR and CD83
(data not shown).
Expression of CD3 Subunits but Not TCR-b Chain in
CD41CD32CD142  PBMC. Although the pTa1 periph-
eral blood cell population does not express CD3 on the cell
surface, as assessed by FACSÒ analysis, we investigated
whether transcripts for the different components of this
TCR-associated signalling molecule could be detected. For
this purpose, cDNA from CD41CD32CD142 sorted cells
was amplified with three different sets of primers specific
for CD3-g, CD3-e, and CD3-d transcripts, respectively.
Analysis of the PCR products showed that CD41CD32
CD142 cells expressed all three CD3 components, as can
be observed in the T cell line MOLT 4 (Fig. 5 A); CD3-g
was found to be expressed in low amount, because it ap-
peared barely detectable on agarose gels after staining with
ethidium bromide; nonetheless, the presence of the mes-
sage was readily detectable after hybridization with a spe-
cific internal probe of the blotted PCR products (data not
shown).
The concomitant expression of transcripts of pTa and
CD3 components in the CD41CD32CD142 cell popula-
tion, together with the described rearrangement of TCR-b
genes, raised the possibility that, at this stage, such cells
might assemble in their cytoplasm a putative human pre-
TCR complex consisting of a TCR-b chain associated
with the pTa chain. To test this possibility we performed
cytoplasmic staining to detect the presence of TCR-b and
CD3-e proteins in CD41CD32CD142 cells. Flow cyto-
metric analysis shown in Fig. 5 B revealed that while pTa1
cells do not express TCR-b chain in the cytoplasm, all cells
within this population express CD3-e protein, but at lower
levels than in a mature human T cell clone. Specificity of
the CD3-e cytoplasmic staining was confirmed by relevant
controls, and in particular by the lack of any FACSÒ profile
shift in similarly stained B lymphocytes and dendritic cells
(data not shown). The absence of TCR-b chain in the cy-
toplasm of CD41CD32CD142 cells is consistent with lack
of VDJb rearrangements at DNA level (data not shown).
These data indicate that while some components of such
putative human pre-TCR, and in particular CD3-e, are
not only transcribed, but also translated into proteins, oth-
ers, like the TCR-b chain are only present in the form of
D–J transcript, while no translation can be detected.
Only a Fraction of CD41CD32CD142 Expresses pTa.
To define whether all CD41CD32CD142 cells or, on the
other hand, only a fraction of them expressed pTa, we per-
formed PCR-based analysis of pTa expression on discrete
numbers of sorted CD41CD32CD142 PBMC obtained
with the ACDU technique. In brief, 50, 20, 10, or 5
CD41CD32CD142 cells were directly sorted in 96-well
plates and cDNA was synthesized directly in the plates.
Two rounds of PCR followed, a first one on the total
cDNA obtained and a second one on a fraction of the first
Figure 4. Cell surface analysis of pTa1 cells. Mononuclear cells were
separated with standard Ficoll gradient and depleted of CD31 cells with
FITC–TR66 mAb. Three-color analysis was then performed using CD4-
and CD14-specific mAbs in combination with a third antibody of interest
(histograms of which are shown in the figure): in the case of biotinylated
antibodies (CD2, CD10, and HLA-DR), CD4–R-PE and CD14–FITC
and, subsequently, APC were used; in the case of directly PE-labeled an-
tibodies (CD5, CD7, CD33, and CD34), CD4–tricolor and CD14–FITC
were used. When staining with CD33 or B7-2 mAbs we had to sort
CD41CD32CD142 cells, as shown in Fig. 1, and restain them with one
of the two antibodies that were then detected with mouse anti–human
IgG2.880 Immature T Cells in Human Peripheral Blood
PCR product (2 ml). For both PCRs, the same pTa-spe-
cific primers were used.
When we initially restricted our analysis to duplicates of
each sorted cell aliquots (50, 20, 10, 5, cells; Fig. 6, top left),
a positive reaction could be detected in all the wells, down
to the ones that contained 5 cells/well. To try and get a
more accurate and reliable estimate of the frequency, ten
separate PCR reactions were run, each on a well contain-
ing 5 cells (Fig. 6, top right). The analysis of the results
showed a positive signal in 50% of the samples. Assuming
that our PCR was 100% efficient on these 5-cell samples, a
frequency of pTa1 cells of 1⁄7 can be calculated using Pois-
son’s equation.
Next, we asked whether differences existed in the fre-
quency of pTa1 cells in the two subsets that could be iden-
tified by differential expression of CD2. Therefore, we sep-
arated our starting population into CD21 and CD22 (see
Fig. 4) subsets and performed the same PCR-based analy-
sis. This showed an enriched pTa1 cell frequency in the
CD22 subset where all samples containing 5 cells/well
Figure 5. (A) CD3-g, CD3-e,
and CD3-d transcripts are ex-
pressed in pTa1 cells. RT–PCR
analysis with primers specific for
three components (g, e, and d)
of the CD3 signaling molecule
was performed on CD41
CD32CD142 cell population.
The T cell line MOLT4 and wa-
ter were used as positive and
negative controls, respectively.
(B) CD3-e molecule, but not
TCR  b chain, is present in the
cytoplasm of pTa1 cells. Cyto-
plasmic staining was performed
with a TCR-b–specific (top right
and left) or a CD3-e–specific (bot-
tom right and left) mAbs on a T
cell clone (right top and bottom)
and on CD41CD32CD142
sorted PBMC (left top and bot-
tom). In the case of TCR-b cy-
toplasmic staining, mouse anti–
human IgG1 was subsequently
used. Dotted histogram lines
represent negative controls that
were the following: for b-cyto-
plasmic, mouse anti–human
IgG1 alone and for CD3-cyto-
plasmic, CD20–FITC.881 Bruno et al.
scored positive, whereas only 50% of the samples contain-
ing 10 cells/well showed a positive PCR reaction in the
CD21 subset (Fig. 6, bottom).
T Cell Differentiation Potential. The fact that the CD41CD32
CD142 PB cell population was found to express CD3-g,
CD3-d, and CD3-e, pTa, and RAG-1 transcripts, and has
partially rearranged the TCR-b locus strongly suggested
that committed T cell precursors were present. Moreover,
the phenotype of these cells resembles that of the CD32
CD41CD82 ISP thymocytes. These latter cells differentiate
into DP and CD41TCR-ab1 cells in mouse FTOC. To
analyze the T cell developmental potential, CD41CD32
CD142 peripheral blood cells were introduced into FTOC.
After 3 wk of incubation only few human cells were recov-
ered from the FTOC with CD41CD32CD142 peripheral
blood cells. To determine accurately the phenotype of these
cells, we stained with anti-CD45, anti-CD4, and anti-CD3
or anti-CD8. Fig. 7 shows that almost all human cells ex-
pressed high levels of CD3 and CD4. The CD41 cells
completely lack CD8. This pattern of differentiation is dis-
tinct from what we observe with CD32CD41CD82 ISP
thymocytes, which give rise to a majority of DP and SP
cells (Fig. 7).
As the CD22 and CD21 fractions were differentially en-
riched in pTa-expressing cells, we asked whether either
population could give rise to mature T cells when cultured
in the presence of irradiated feeder cells, IL-2, IL-7, and
PHA. CD32CD41CD82 thymocytes are completely un-
able to grow under these conditions (Spits, H., unpublished
data). However, when 1 3 105 sorted potential precursor
cells were cultured under these conditions, we observed that,
while CD21 cells developed into either CD41CD31 re-
sembling mature T cells or CD41CD32 cells (Fig. 8 A),
CD22 cells were not able to expand. CD41CD32 cells de-
veloping from the CD21 fraction were found to have CD3
and TCR-b proteins in the cytoplasm and, after restimula-
tion, gradually acquired CD3 surface expression (data not
shown). pTa expression was not present in both CD41
CD31 and CD41CD32 phenotypes obtained (data not
shown).
To characterize further the progeny obtained from
CD41CD32CD142 starting population, we cloned it by
limiting dilution. Cloning frequencies ranging from 5 to 10%
were observed in five different experiments performed; in
addition, according to what was previously shown in bulk
culture experiments, all clones were CD41, but expressed
different levels of CD3 molecule on the cell surface, vary-
Figure 6. pTa expression in
the CD22 and CD21 of
CD41CD32  CD142 cells. Lim-
ited amounts (50, 20, 10, 5) of
CD41CD32CD142 cells were
directly sorted in 96-well plates
and analyzed for the expression
of pTa gene by two rounds of
PCR using the same primers (top
right and left). The analysis was
first performed on different cell
numbers in duplicate (top left)
and then on the same cell num-
ber 10 times (top right). In the
bottom panel, the same analysis
on different cell numbers (20,
10, 5, 1) in duplicate of CD22
and CD21 fractions of CD41
CD32CD142 cells is shown.
CD41CD32CD142 total sorted
cell population and water were
the positive and negative con-
trols, respectively.
Figure 7. The capacities of CD41CD32CD142 PBMC and CD41
CD32CD82thymocytes of developing into T cells in an FTOC. PBMC
and thymocytes were cultured for 3 wk with mouse RAG-1 2/2 thymic
lobes as indicated in Materials and Methods and analyzed with PE, FITC,
and tricolor-labeled mAbs against CD45 (to discriminate between mouse
and human cells) CD3, CD4, and CD8.882 Immature T Cells in Human Peripheral Blood
ing from CD3high to CD32. In Fig. 8 B, some representa-
tive clones are shown; interestingly, some of them were
characterized by a smear in CD3 expression. All the differ-
ent clones obtained, independently from their level of CD3
expression, became, after repeated stimulations, CD3high
and TCR-ab1, suggesting that stimulation favored the as-
sembling of a functional TCR on the cell surface.
Discussion
In the present work, we describe a novel population of
T cell progenitors present in human peripheral blood. This
cell population lacks CD3 on the cell membrane, expresses
CD4, but not the early hematopoietic progenitor cell marker
CD34. The latter molecule has been shown to be expressed
on all of the early T cell progenitor populations described
until now, both inside (19) and outside the thymus (17,
20–22). Despite the absence of CD34, these cells have
characteristics of committed T cell progenitors. Specifi-
cally, these cells show partial TCR-b locus rearrangements
(DJ but not VDJ) and have transcripts of genes of pTa and
RAG-1. Moreover, these cells express CD3-d, CD3-g, and
CD3-e genes. The fact that these CD41CD32 cells do not
express CD34 and that they were found to be the only
fraction in total PBMC positive for pTa, is in contrast with
some recently published data (7) in which CD341 cells iso-
lated from both adult and cord blood (CB) were found to
be pTa1. We failed to detect pTa message in CD341 cells
present in either PB (data not shown) and CB (Blom, B.,
and H. Spits, manuscript in preparation). This discrepancy
may be due to differences in the purification of CD341
cells; moreover, CD341 cells were obtained with G-CSF
treatment (7); it is possible that in this way pTa1 cells are
mobilized from bone marrow, where we can detect pTa
RNA in CD341 cells (data not shown).
Cells within this population can develop into CD41
TCR-ab1 cells in both FTOC as well as with IL-2, IL-7,
and PHA. This latter development is not due to selective
outgrowth of mature T cells, because the cloning efficiency
(5–10%) is much higher than the theoretical contamination
of cell surface CD31 cells (0.1–0.5%). In addition, the pos-
sibility that CD41CD32CD142 cells are derived from acti-
vated mature CD41 T cells that have downregulated the
TCR seems to be highly unlikely because, in contrast with
mature T cells, these cells do not express the TCR-b pro-
tein in the cytoplasm. Moreover, also the relatively low
levels of CD3-e protein in the cytoplasm, size and cell
complexity (FSC versus SSC) distinguish the CD41CD32
CD142 cells from mature T cells.
The development of CD41CD32CD142 peripheral blood
cells into CD41TCR-ab1 cells in both a human/mouse
hybrid FTOC as well as with IL-2, IL-7, and PHA clearly
demonstrates the presence of T cell precursors in adult
PBMC and could suggest that they are prothymocytes on
their way to the thymus. Cells, similar to the CD41 pe-
ripheral blood cells, with partial DJb rearrangements and
pTa gene expression have been identified in day 15.5 mu-
rine fetal blood and were shown to be able to home in the
Figure 8. CD3low to CD3high
T cells can be generated from the
CD21 fraction of CD41CD32
CD142 PB cell population. (A)
FACSÒ profile of cultured CD21,
CD41CD32CD142 cells after
10 d of growth in IL-2, IL-7,
PHA in the presence of alloge-
neic irradiated feeder cells. Dou-
ble staining with CD4–PE and
CD3–FITC is shown. (B) FACSÒ
profiles of some representative
clones obtained by limiting dilu-
tion of CD41CD32CD142 sorted
cells. Culture conditions used were
the same as described above for
bulk cultures. Double staining
with CD4–PE and CD3–FITC
is shown.883 Bruno et al.
thymus and to give rise to DP and SP thymocytes (23). A
fraction (z65%) of these fetal blood murine cells also ex-
pressed CD4 (Rodewald, H.R., personal communication).
It is possible that the CD41CD32CD142 PBMC are the
direct precursors of the CD32CD41CD82 ISP cells in the
thymus. These latter cells are actively dividing, express
CD1, CD5, and CD7, and develop into DP and SP cells in
an FTOC and in human thymic fragments transplanted
SCID mice. However, although CD41CD32CD142 cells
and CD32CD41CD82 ISP thymocytes share expression of
CD4 and of pTa, the two populations are distinct both
with respect to phenotypic and differentiation characteris-
tics (Table 1). The most conspicuous phenotypic difference
concerns the expression of CD1a, which is present on all
ISP thymocytes but not on the CD41CD32CD142 PBMC
and CD45RA, which has an opposite expression pattern.
More importantly, CD41CD32CD142 PBMC are not
able to develop in the hybrid human/mouse FTOC in
double positive (DP) cells, but only into single-positive
(SP) CD41CD31 cells, whereas DP and few CD31 SP are
obtained from ISP thymocytes in the same experimental
conditions. Moreover, it is impossible to expand ISP thy-
mocytes with IL-2, IL-7, PHA, and feeder cells as observed
for CD41CD32CD142 PBMC both in bulk culture and in
limiting dilution (results not shown). If these CD32CD41
PBMC are prothymocytes, one should assume that cells of
different developmental stages can enter the thymus, be-
cause the thymus also contains CD341CD12 progenitor cells
with the TCR in germline configuration and the capacity
to develop into T cells, DC, and NK cells (18). One should
also expect to find a population that is intermediate be-
tween CD32CD41 PBMC and ISP thymocytes. Such a
population has not yet been described in the human thy-
mus. Based on the fact that the thymus in adults is severely
involuted, it may be reasoned that there is not an influx of
new progenitors into the thymus in adults. This notion, to-
gether with the observations pointing to substantial differ-
ences with ISP thymic precursors, in particular with respect
to the capacity to develop into DP cells in a FTOC, could
raise the alternative possibility that CD41CD32CD142
cells represent an extrathymic pathway of T cell develop-
ment. Studies with nude mice have shown that mature T cells
can develop in aged mice in the absence of a thymus (24),
indicating that this organ is not required for development
of some T cells. CD32Thy-1low cells have been found in the
bone marrow of nude mice that have partial DJ rearrange-
ments of the TCR-b locus (25). A transcript containing
TCR-b constant region sequences but not variable region
sequences was amplified, suggesting that an unrearranged
TCR-b gene locus is transcriptionally active in this bone
marrow population. These characteristics of Thy-1lowCD32
cells in nude bone marrow cells are very similar to those of
the CD32CD41 PBMC population described here. T cells
that develop in nude mice have a different TCR-Vb reper-
toire than euthymic controls (26) and some TCR-Vb can be
expressed on extrathymically developed cells that are de-
leted in euthymic controls (27). The TCR-Vb repertoire
of the CD31 cells that develop from the CD41CD32
CD142 has not yet been investigated in detail. However,
we can exclude that these circulating PBMC are the pre-
cursors of those T cells that express a monomorphic TCR
(Va24, Vb11) (28, 29), because none of the CD41CD31
cells developing from CD41CD32CD142 PBMC cells
were found to be Va241Vb111 (data not shown).
Table 1. Phenotypic and Functional Comparison between 
CD32CD41CD82 Immature Single-positive Cells (CD41CD32, 
ISP) Present in Thymus and CD41CD32 Cells Identified in 
Peripheral Blood
Thymus
CD41CD32, ISP
Peripheral
blood
CD41CD32
pTa1 1
cCD3 11
cTCR-b2 2
CD1a 12
CD2 100% 15–40%
CD7 100% 2–5%
CD5 100% 2–5%
CD10 nt 2
CD45Ra6 1
CD33 26
B7-2 nt 1
HLA-DR 11
Cell cycle 111 2
TCR-b locus
DJb rearrangement 11
FTOC DP, SP SP
PHA, IL-2, IL-7 21
nt, not tested. 111, a lot.
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